img

Global and United States Carcinoid Tumor Syndrome Treatment Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Carcinoid Tumor Syndrome Treatment Market Report & Forecast 2024-2034

Carcinoid tumor syndrome is a rare condition caused by a type of tumor called a carcinoid tumor. Carcinoid tumors are usually found in the gastrointestinal tract, but can also occur in other parts of the body such as the lungs and ovaries. These tumors produce hormones and chemicals, including serotonin, that can cause a variety of symptoms in affected individuals. Symptoms can include flushing of the skin, diarrhea, wheezing, abdominal pain, and heart palpitations.
Market Analysis and InsightsGlobal and United States Carcinoid Tumor Syndrome Treatment Market
This report focuses on global and United States Carcinoid Tumor Syndrome Treatment market, also covers the segmentation data of other regions in regional level and county level.
The global Carcinoid Tumor Syndrome Treatment revenue was US$ 1600 million in 2024 and is forecast to a readjusted size of US$ 3299.1 million by 2034 with a CAGR of 10.9% during the forecast period (2024-2034).
In United States the Carcinoid Tumor Syndrome Treatment revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Carcinoid Tumor Syndrome Treatment include Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Biopharmaceuticals, Inc, Sun Pharmaceutical Industries Ltd, Amgen Inc., Entrinsic Health Solutions, Inc., Endo Pharmaceuticals Inc. and Sirtex SIR-Spheres Pty Ltd, etc. The global five biggest players hold a share of % in 2024.
Global Carcinoid Tumor Syndrome Treatment Scope and Market Size
Carcinoid Tumor Syndrome Treatment market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Carcinoid Tumor Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For United States market, this report focuses on the Carcinoid Tumor Syndrome Treatment market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Novartis AG
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Ipsen Biopharmaceuticals, Inc
Sun Pharmaceutical Industries Ltd
Amgen Inc.
Entrinsic Health Solutions, Inc.
Endo Pharmaceuticals Inc.
Sirtex SIR-Spheres Pty Ltd
BTG International Ltd
Segment by Type
Chemotherapy
Biological Therapy
Radio Therapy

Segment by Application


Hospital
Clinic
Home
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Carcinoid Tumor Syndrome Treatment definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Carcinoid Tumor Syndrome Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Carcinoid Tumor Syndrome Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carcinoid Tumor Syndrome Treatment sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Carcinoid Tumor Syndrome Treatment Product Introduction
1.2 Global Carcinoid Tumor Syndrome Treatment Outlook 2018 VS 2024 VS 2034
1.2.1 Global Carcinoid Tumor Syndrome Treatment Sales in US$ Million for the Year 2018-2034
1.2.2 Global Carcinoid Tumor Syndrome Treatment Sales in Volume for the Year 2018-2034
1.3 United States Carcinoid Tumor Syndrome Treatment Outlook 2018 VS 2024 VS 2034
1.3.1 United States Carcinoid Tumor Syndrome Treatment Sales in US$ Million for the Year 2018-2034
1.3.2 United States Carcinoid Tumor Syndrome Treatment Sales in Volume for the Year 2018-2034
1.4 Carcinoid Tumor Syndrome Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of United States Carcinoid Tumor Syndrome Treatment in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Carcinoid Tumor Syndrome Treatment Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.5 Carcinoid Tumor Syndrome Treatment Market Dynamics
1.5.1 Carcinoid Tumor Syndrome Treatment Industry Trends
1.5.2 Carcinoid Tumor Syndrome Treatment Market Drivers
1.5.3 Carcinoid Tumor Syndrome Treatment Market Challenges
1.5.4 Carcinoid Tumor Syndrome Treatment Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Carcinoid Tumor Syndrome Treatment by Type
2.1 Carcinoid Tumor Syndrome Treatment Market Segment by Type
2.1.1 Chemotherapy
2.1.2 Biological Therapy
2.1.3 Radio Therapy
2.2 Global Carcinoid Tumor Syndrome Treatment Market Size by Type
2.2.1 Global Carcinoid Tumor Syndrome Treatment Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Carcinoid Tumor Syndrome Treatment Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 United States Carcinoid Tumor Syndrome Treatment Market Size by Type
2.3.1 United States Carcinoid Tumor Syndrome Treatment Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 United States Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 United States Carcinoid Tumor Syndrome Treatment Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Carcinoid Tumor Syndrome Treatment by Application
3.1 Carcinoid Tumor Syndrome Treatment Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Home
3.2 Global Carcinoid Tumor Syndrome Treatment Market Size by Application
3.2.1 Global Carcinoid Tumor Syndrome Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Carcinoid Tumor Syndrome Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 United States Carcinoid Tumor Syndrome Treatment Market Size by Application
3.3.1 United States Carcinoid Tumor Syndrome Treatment Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 United States Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 United States Carcinoid Tumor Syndrome Treatment Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Carcinoid Tumor Syndrome Treatment Competitor Landscape by Company
4.1 Global Carcinoid Tumor Syndrome Treatment Market Size by Company
4.1.1 Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Ranked by Revenue (2024)
4.1.2 Global Carcinoid Tumor Syndrome Treatment Revenue by Manufacturer (2018-2023)
4.1.3 Global Carcinoid Tumor Syndrome Treatment Sales by Manufacturer (2018-2023)
4.1.4 Global Carcinoid Tumor Syndrome Treatment Price by Manufacturer (2018-2023)
4.2 Global Carcinoid Tumor Syndrome Treatment Concentration Ratio (CR)
4.2.1 Carcinoid Tumor Syndrome Treatment Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Carcinoid Tumor Syndrome Treatment in 2024
4.2.3 Global Carcinoid Tumor Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Product Offered and Application
4.5 Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Carcinoid Tumor Syndrome Treatment Market Size by Company
4.7.1 Key Players of Carcinoid Tumor Syndrome Treatment in United States, Ranked by Revenue (2024)
4.7.2 United States Carcinoid Tumor Syndrome Treatment Revenue by Players (2018-2023)
4.7.3 United States Carcinoid Tumor Syndrome Treatment Sales by Players (2018-2023)
5 Global Carcinoid Tumor Syndrome Treatment Market Size by Region
5.1 Global Carcinoid Tumor Syndrome Treatment Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Carcinoid Tumor Syndrome Treatment Market Size in Volume by Region (2018-2034)
5.2.1 Global Carcinoid Tumor Syndrome Treatment Sales in Volume by Region: 2018-2023
5.2.2 Global Carcinoid Tumor Syndrome Treatment Sales in Volume Forecast by Region (2024-2034)
5.3 Global Carcinoid Tumor Syndrome Treatment Market Size in Value by Region (2018-2034)
5.3.1 Global Carcinoid Tumor Syndrome Treatment Sales in Value by Region: 2018-2023
5.3.2 Global Carcinoid Tumor Syndrome Treatment Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Carcinoid Tumor Syndrome Treatment Market Size YoY Growth 2018-2034
6.2 Americas Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Carcinoid Tumor Syndrome Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Carcinoid Tumor Syndrome Treatment Market Size YoY Growth 2018-2034
7.2 EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Carcinoid Tumor Syndrome Treatment Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Carcinoid Tumor Syndrome Treatment Market Size YoY Growth 2018-2034
8.2 China Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Carcinoid Tumor Syndrome Treatment Market Size YoY Growth 2018-2034
9.2 APAC Carcinoid Tumor Syndrome Treatment Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Carcinoid Tumor Syndrome Treatment Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Carcinoid Tumor Syndrome Treatment Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Carcinoid Tumor Syndrome Treatment Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Carcinoid Tumor Syndrome Treatment Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Novartis AG
10.1.1 Novartis AG Company Information
10.1.2 Novartis AG Description and Business Overview
10.1.3 Novartis AG Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis AG Carcinoid Tumor Syndrome Treatment Products Offered
10.1.5 Novartis AG Recent Development
10.2 Teva Pharmaceutical Industries Ltd.
10.2.1 Teva Pharmaceutical Industries Ltd. Company Information
10.2.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
10.2.3 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Products Offered
10.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
10.3 Mylan N.V.
10.3.1 Mylan N.V. Company Information
10.3.2 Mylan N.V. Description and Business Overview
10.3.3 Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mylan N.V. Carcinoid Tumor Syndrome Treatment Products Offered
10.3.5 Mylan N.V. Recent Development
10.4 Ipsen Biopharmaceuticals, Inc
10.4.1 Ipsen Biopharmaceuticals, Inc Company Information
10.4.2 Ipsen Biopharmaceuticals, Inc Description and Business Overview
10.4.3 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Products Offered
10.4.5 Ipsen Biopharmaceuticals, Inc Recent Development
10.5 Sun Pharmaceutical Industries Ltd
10.5.1 Sun Pharmaceutical Industries Ltd Company Information
10.5.2 Sun Pharmaceutical Industries Ltd Description and Business Overview
10.5.3 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Products Offered
10.5.5 Sun Pharmaceutical Industries Ltd Recent Development
10.6 Amgen Inc.
10.6.1 Amgen Inc. Company Information
10.6.2 Amgen Inc. Description and Business Overview
10.6.3 Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Amgen Inc. Carcinoid Tumor Syndrome Treatment Products Offered
10.6.5 Amgen Inc. Recent Development
10.7 Entrinsic Health Solutions, Inc.
10.7.1 Entrinsic Health Solutions, Inc. Company Information
10.7.2 Entrinsic Health Solutions, Inc. Description and Business Overview
10.7.3 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Products Offered
10.7.5 Entrinsic Health Solutions, Inc. Recent Development
10.8 Endo Pharmaceuticals Inc.
10.8.1 Endo Pharmaceuticals Inc. Company Information
10.8.2 Endo Pharmaceuticals Inc. Description and Business Overview
10.8.3 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Products Offered
10.8.5 Endo Pharmaceuticals Inc. Recent Development
10.9 Sirtex SIR-Spheres Pty Ltd
10.9.1 Sirtex SIR-Spheres Pty Ltd Company Information
10.9.2 Sirtex SIR-Spheres Pty Ltd Description and Business Overview
10.9.3 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Products Offered
10.9.5 Sirtex SIR-Spheres Pty Ltd Recent Development
10.10 BTG International Ltd
10.10.1 BTG International Ltd Company Information
10.10.2 BTG International Ltd Description and Business Overview
10.10.3 BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales, Revenue and Gross Margin (2018-2023)
10.10.4 BTG International Ltd Carcinoid Tumor Syndrome Treatment Products Offered
10.10.5 BTG International Ltd Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Carcinoid Tumor Syndrome Treatment Industry Chain Analysis
11.2 Carcinoid Tumor Syndrome Treatment Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Carcinoid Tumor Syndrome Treatment Production Mode & Process
11.4 Carcinoid Tumor Syndrome Treatment Sales and Marketing
11.4.1 Carcinoid Tumor Syndrome Treatment Sales Channels
11.4.2 Carcinoid Tumor Syndrome Treatment Distributors
11.5 Carcinoid Tumor Syndrome Treatment Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Carcinoid Tumor Syndrome Treatment CAGR in Value, United States VS Global, 2018 VS 2024 VS 2034
Table 2. Carcinoid Tumor Syndrome Treatment Market Trends
Table 3. Carcinoid Tumor Syndrome Treatment Market Drivers
Table 4. Carcinoid Tumor Syndrome Treatment Market Challenges
Table 5. Carcinoid Tumor Syndrome Treatment Market Restraints
Table 6. Global Carcinoid Tumor Syndrome Treatment Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Carcinoid Tumor Syndrome Treatment Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Carcinoid Tumor Syndrome Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Carcinoid Tumor Syndrome Treatment Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Carcinoid Tumor Syndrome Treatment Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Carcinoid Tumor Syndrome Treatment Revenue Share by Manufacturer, 2018-2023
Table 13. Global Carcinoid Tumor Syndrome Treatment Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Carcinoid Tumor Syndrome Treatment Sales Share by Manufacturer, 2018-2023
Table 15. Global Carcinoid Tumor Syndrome Treatment Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Carcinoid Tumor Syndrome Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Carcinoid Tumor Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoid Tumor Syndrome Treatment as of 2024)
Table 18. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Product Offered and Application
Table 20. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Carcinoid Tumor Syndrome Treatment in United States, Ranked by Revenue (2024) & (US$ million)
Table 23. United States Carcinoid Tumor Syndrome Treatment Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States Carcinoid Tumor Syndrome Treatment Revenue Share by Players, (2018-2023)
Table 25. United States Carcinoid Tumor Syndrome Treatment Sales by Players, (K Units), (2018-2023)
Table 26. United States Carcinoid Tumor Syndrome Treatment Sales Share by Players, (2018-2023)
Table 27. Global Carcinoid Tumor Syndrome Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Carcinoid Tumor Syndrome Treatment Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Carcinoid Tumor Syndrome Treatment Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Carcinoid Tumor Syndrome Treatment Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Carcinoid Tumor Syndrome Treatment Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Carcinoid Tumor Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Carcinoid Tumor Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Carcinoid Tumor Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Carcinoid Tumor Syndrome Treatment Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Carcinoid Tumor Syndrome Treatment Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Novartis AG Company Information
Table 48. Novartis AG Description and Business Overview
Table 49. Novartis AG Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Novartis AG Carcinoid Tumor Syndrome Treatment Product
Table 51. Novartis AG Recent Development
Table 52. Teva Pharmaceutical Industries Ltd. Company Information
Table 53. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 54. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Product
Table 56. Teva Pharmaceutical Industries Ltd. Recent Development
Table 57. Mylan N.V. Company Information
Table 58. Mylan N.V. Description and Business Overview
Table 59. Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Mylan N.V. Carcinoid Tumor Syndrome Treatment Product
Table 61. Mylan N.V. Recent Development
Table 62. Ipsen Biopharmaceuticals, Inc Company Information
Table 63. Ipsen Biopharmaceuticals, Inc Description and Business Overview
Table 64. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Product
Table 66. Ipsen Biopharmaceuticals, Inc Recent Development
Table 67. Sun Pharmaceutical Industries Ltd Company Information
Table 68. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 69. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Product
Table 71. Sun Pharmaceutical Industries Ltd Recent Development
Table 72. Amgen Inc. Company Information
Table 73. Amgen Inc. Description and Business Overview
Table 74. Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Amgen Inc. Carcinoid Tumor Syndrome Treatment Product
Table 76. Amgen Inc. Recent Development
Table 77. Entrinsic Health Solutions, Inc. Company Information
Table 78. Entrinsic Health Solutions, Inc. Description and Business Overview
Table 79. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Product
Table 81. Entrinsic Health Solutions, Inc. Recent Development
Table 82. Endo Pharmaceuticals Inc. Company Information
Table 83. Endo Pharmaceuticals Inc. Description and Business Overview
Table 84. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Product
Table 86. Endo Pharmaceuticals Inc. Recent Development
Table 87. Sirtex SIR-Spheres Pty Ltd Company Information
Table 88. Sirtex SIR-Spheres Pty Ltd Description and Business Overview
Table 89. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Product
Table 91. Sirtex SIR-Spheres Pty Ltd Recent Development
Table 92. BTG International Ltd Company Information
Table 93. BTG International Ltd Description and Business Overview
Table 94. BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. BTG International Ltd Carcinoid Tumor Syndrome Treatment Product
Table 96. BTG International Ltd Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Carcinoid Tumor Syndrome Treatment Customers List
Table 100. Carcinoid Tumor Syndrome Treatment Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Carcinoid Tumor Syndrome Treatment Product Picture
Figure 2. Global Carcinoid Tumor Syndrome Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Carcinoid Tumor Syndrome Treatment Market Size 2018-2034 (US$ Million)
Figure 4. Global Carcinoid Tumor Syndrome Treatment Sales 2018-2034 (K Units)
Figure 5. United States Carcinoid Tumor Syndrome Treatment Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. United States Carcinoid Tumor Syndrome Treatment Market Size 2018-2034 (US$ Million)
Figure 7. United States Carcinoid Tumor Syndrome Treatment Sales 2018-2034 (K Units)
Figure 8. United States Carcinoid Tumor Syndrome Treatment Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. United States Carcinoid Tumor Syndrome Treatment Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Carcinoid Tumor Syndrome Treatment Report Years Considered
Figure 11. Product Picture of Chemotherapy
Figure 12. Product Picture of Biological Therapy
Figure 13. Product Picture of Radio Therapy
Figure 14. Global Carcinoid Tumor Syndrome Treatment Market Share by Type in 2024 & 2034
Figure 15. Global Carcinoid Tumor Syndrome Treatment Sales in Value by Type (2018-2034) & (US$ Million)
Figure 16. Global Carcinoid Tumor Syndrome Treatment Sales Market Share in Value by Type (2018-2034)
Figure 17. Global Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 18. Global Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 19. Global Carcinoid Tumor Syndrome Treatment Price by Type (2018-2034) & (US$/Unit)
Figure 20. United States Carcinoid Tumor Syndrome Treatment Market Share by Type in 2024 & 2034
Figure 21. United States Carcinoid Tumor Syndrome Treatment Sales in Value by Type (2018-2034) & (US$ Million)
Figure 22. United States Carcinoid Tumor Syndrome Treatment Sales Market Share in Value by Type (2018-2034)
Figure 23. United States Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 24. United States Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 25. United States Carcinoid Tumor Syndrome Treatment Price by Type (2018-2034) & (US$/Unit)
Figure 26. Product Picture of Hospital
Figure 27. Product Picture of Clinic
Figure 28. Product Picture of Home
Figure 29. Global Carcinoid Tumor Syndrome Treatment Market Share by Application in 2024 & 2034
Figure 30. Global Carcinoid Tumor Syndrome Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 31. Global Carcinoid Tumor Syndrome Treatment Sales Market Share in Value by Application (2018-2034)
Figure 32. Global Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 33. Global Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 34. Global Carcinoid Tumor Syndrome Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 35. United States Carcinoid Tumor Syndrome Treatment Market Share by Application in 2024 & 2034
Figure 36. United States Carcinoid Tumor Syndrome Treatment Sales in Value by Application (2018-2034) & (US$ Million)
Figure 37. United States Carcinoid Tumor Syndrome Treatment Sales Market Share in Value by Application (2018-2034)
Figure 38. United States Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 39. United States Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 40. United States Carcinoid Tumor Syndrome Treatment Price by Application (2018-2034) & (US$/Unit)
Figure 41. Americas Carcinoid Tumor Syndrome Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 42. Americas Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 43. Americas Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 44. Americas Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 45. Americas Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 46. Americas Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 47. United States Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 48. Canada Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 49. Mexico Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. EMEA Carcinoid Tumor Syndrome Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 52. EMEA Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 53. EMEA Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 54. EMEA Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 55. EMEA Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 56. EMEA Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 57. Europe Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 58. Middle East Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 59. Africa Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. China Carcinoid Tumor Syndrome Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 61. China Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 62. China Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 63. China Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 64. China Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 65. China Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 66. APAC Carcinoid Tumor Syndrome Treatment Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 67. APAC Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 68. APAC Carcinoid Tumor Syndrome Treatment Sales by Type (2018-2034) & (K Units)
Figure 69. APAC Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Type (2018-2034)
Figure 70. APAC Carcinoid Tumor Syndrome Treatment Sales by Application (2018-2034) & (K Units)
Figure 71. APAC Carcinoid Tumor Syndrome Treatment Sales Market Share in Volume by Application (2018-2034)
Figure 72. Japan Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 73. South Korea Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 74. China Taiwan Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. India Carcinoid Tumor Syndrome Treatment Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Carcinoid Tumor Syndrome Treatment Value Chain
Figure 78. Carcinoid Tumor Syndrome Treatment Production Process
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed